Document is current

Article History

Received: 20 November 2023

Accepted: 13 January 2024

First Online: 5 February 2024

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki. According to local regulations (§ 15 Berufsordnung, Ärztekammer Nordrhein), ethics approval and study formal consent was not required for this study due to its retrospective epidemiological nature.

: Not applicable.

: <b>V. Schoeneberger</b> has nothing to disclose. <b>J. Li</b> has nothing to disclose. <b>L. Menghesha</b> has nothing to disclose. <b>F. Holz</b> reports personal fees from Acucela, grants and personal fees from Allergan, grants and personal fees from Bayer, personal fees from Bioeq, personal fees from Boehringer Ingelheim, grants and personal fees from Carl Zeiss Meditec, grants and personal fees from Genentech, grants and personal fees from Heidelberg Engineering, personal fees from Merz, personal fees from NightstarX, grants and personal fees from Novartis, personal fees from Optos, personal fees from Pixium, personal fees from Roche, and personal fees from Thea, outside the submitted work. <b>F. Schaub</b> has nothing to disclose. <b>T. Krohne</b> reports personal fees from Alimera Sciences, personal fees from Allergan/AbbVie, grants and personal fees from Bayer, personal fees from Heidelberg Engineering, grants and personal fees from Novartis, personal fees from Roche, and personal fees from Stada, outside the submitted work.